Indeed, some brain-tumor bearing mouse studies have demonstrated that increasing brain VEGF levels increases mLV flow to increase T cell responsivity at cervical lymph nodes, which then produces a more vigorous immune response against the brain tumor, resulting in tumor regression [71]. The gene discussed is VEGFA; the disease is brain neoplasm.